Eximia Research acquires Integrated Clinical Trial Services
Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical Trial Services (ICTS).…
Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical Trial Services (ICTS).…
Myriad Genetics has announced five research collaborations with health institutions to study the use of its Precise MRD test in…
In a bid to “strengthen its balance sheet”, Avantor has signed a definitive agreement to divest its clinical services business…
Vir Biotechnology has signed a licensing agreement with Sanofi for three clinical-stage masked T-cell engagers (TCE) for cancer treatment. The…
Otsuka Pharmaceutical is looking to acquire US-based Jnana Therapeutics in a deal worth up to approximately $1.1bn. The Japanese company…
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
XyloCor Therapeutics has signed a licencing agreement with SmartWise, a subunit of SmartCella Holding, to use the latter’s Extroducer infusion…
Tectonic Therapeutic has completed a reverse merger with Avrobio and will begin trading on the Nasdaq global market as Tectonic…
Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio…
AstraZeneca has committed to $80m in non-dilutive funding to Swiss biotech SixPeak Bio, which is developing a bispecific antibody therapy…